Sign up to our newsletter Subscribe
Are Recommendations for HTA of Gene Therapies Being Achieved?
Research & Publications
Original research is at the heart of what we do. For more than 60 years, our experts have published across a wide range of topics from the fundamentals of health economics itself to the challenges facing health care in the UK and internationally.
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
